Daniella Beckman

Insider Reports History

Entity
Individual
Location
C/O Idenix Pharmaceuticals, Inc., One Kendall Square, Bldg. 1400, Cambridge, MA
Signature
/s/ Douglas Barry, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Daniella Beckman:

Insider Reports Filed by Daniella Beckman

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TNGX Tango Therapeutics, Inc. Feb 4, 2025 2 -$25.3K 4 Feb 6, 2025 Chief Financial Officer
TNGX Tango Therapeutics, Inc. Feb 3, 2025 2 $0 4 Feb 5, 2025 Chief Financial Officer
UPB Upstream Bio, Inc. Oct 10, 2024 1 $0 4 Oct 15, 2024 Director
UPB Upstream Bio, Inc. Oct 10, 2024 0 $0 3 Oct 10, 2024 Director
BPMC Blueprint Medicines Corp Jun 12, 2024 2 $0 4 Jun 14, 2024 Director
VOR Vor Biopharma Inc. May 23, 2024 1 $0 4 May 28, 2024 Director
TNGX Tango Therapeutics, Inc. Feb 6, 2024 2 -$46.9K 4 Feb 8, 2024 Chief Financial Officer
TNGX Tango Therapeutics, Inc. Feb 1, 2024 2 $0 4 Feb 5, 2024 Chief Financial Officer
BPMC Blueprint Medicines Corp Jun 21, 2023 2 $0 4 Jun 23, 2023 Director
VOR Vor Biopharma Inc. May 26, 2023 1 $0 4 Jun 2, 2023 Director
TNGX Tango Therapeutics, Inc. Mar 1, 2023 2 $0 4 Mar 2, 2023 Chief Financial Officer
BPMC Blueprint Medicines Corp Jun 21, 2022 2 $0 4 Jun 30, 2022 Director
VOR Vor Biopharma Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
TNGX Tango Therapeutics, Inc. Feb 1, 2022 1 $0 4 Feb 3, 2022 Chief Financial Officer
BPMC Blueprint Medicines Corp Dec 8, 2021 2 $0 4/A Mar 31, 2022 Director
BPMC Blueprint Medicines Corp Dec 8, 2021 0 $0 3/A Mar 31, 2022 Director
TBIO Translate Bio, Inc. Sep 14, 2021 4 $0 4 Sep 14, 2021 Director
TNGX Tango Therapeutics, Inc. Aug 12, 2021 1 $0 4 Aug 16, 2021 Chief Financial Officer
TNGX Tango Therapeutics, Inc. Aug 10, 2021 0 $0 3 Aug 12, 2021 Chief Financial Officer
TBIO Translate Bio, Inc. Jun 16, 2021 1 $0 4 Jun 16, 2021 Director